nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclopentolate—BCHE—Irinotecan—stomach cancer	0.386	1	CbGbCtD
Cyclopentolate—BCHE—diaphragm—stomach cancer	0.0634	0.353	CbGeAlD
Cyclopentolate—CHRM3—muscle of abdomen—stomach cancer	0.0622	0.347	CbGeAlD
Cyclopentolate—Lacrimation—Floxuridine—stomach cancer	0.0244	0.0756	CcSEcCtD
Cyclopentolate—Lacrimation increased—Floxuridine—stomach cancer	0.0156	0.0482	CcSEcCtD
Cyclopentolate—Photophobia—Floxuridine—stomach cancer	0.0135	0.0417	CcSEcCtD
Cyclopentolate—Punctate keratitis—Capecitabine—stomach cancer	0.0129	0.0401	CcSEcCtD
Cyclopentolate—Gastroenteritis—Floxuridine—stomach cancer	0.0117	0.0364	CcSEcCtD
Cyclopentolate—Disorientation—Floxuridine—stomach cancer	0.0116	0.036	CcSEcCtD
Cyclopentolate—Lacrimation—Irinotecan—stomach cancer	0.00831	0.0257	CcSEcCtD
Cyclopentolate—Lacrimation—Fluorouracil—stomach cancer	0.00796	0.0247	CcSEcCtD
Cyclopentolate—CHRM3—smooth muscle tissue—stomach cancer	0.00714	0.0398	CbGeAlD
Cyclopentolate—BCHE—hematopoietic system—stomach cancer	0.00661	0.0369	CbGeAlD
Cyclopentolate—Drowsiness—Mitomycin—stomach cancer	0.00629	0.0195	CcSEcCtD
Cyclopentolate—BCHE—smooth muscle tissue—stomach cancer	0.00583	0.0325	CbGeAlD
Cyclopentolate—Lacrimation—Docetaxel—stomach cancer	0.00574	0.0178	CcSEcCtD
Cyclopentolate—CHRM3—digestive system—stomach cancer	0.00564	0.0314	CbGeAlD
Cyclopentolate—Vasodilation—Irinotecan—stomach cancer	0.00556	0.0172	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Irinotecan—stomach cancer	0.00556	0.0172	CcSEcCtD
Cyclopentolate—Lacrimation increased—Irinotecan—stomach cancer	0.0053	0.0164	CcSEcCtD
Cyclopentolate—CHRM1—endocrine gland—stomach cancer	0.0052	0.029	CbGeAlD
Cyclopentolate—Lacrimation increased—Fluorouracil—stomach cancer	0.00508	0.0157	CcSEcCtD
Cyclopentolate—CHRM3—endocrine gland—stomach cancer	0.00466	0.026	CbGeAlD
Cyclopentolate—Vision blurred—Mitomycin—stomach cancer	0.00464	0.0144	CcSEcCtD
Cyclopentolate—BCHE—digestive system—stomach cancer	0.0046	0.0256	CbGeAlD
Cyclopentolate—Photophobia—Fluorouracil—stomach cancer	0.00439	0.0136	CcSEcCtD
Cyclopentolate—Coma—Fluorouracil—stomach cancer	0.00428	0.0132	CcSEcCtD
Cyclopentolate—BCHE—bone marrow—stomach cancer	0.00424	0.0236	CbGeAlD
Cyclopentolate—Lacrimation—Epirubicin—stomach cancer	0.00387	0.012	CcSEcCtD
Cyclopentolate—BCHE—endocrine gland—stomach cancer	0.0038	0.0212	CbGeAlD
Cyclopentolate—Disorientation—Fluorouracil—stomach cancer	0.0038	0.0118	CcSEcCtD
Cyclopentolate—Lacrimation increased—Docetaxel—stomach cancer	0.00367	0.0114	CcSEcCtD
Cyclopentolate—Lacrimation—Doxorubicin—stomach cancer	0.00359	0.0111	CcSEcCtD
Cyclopentolate—Somnolence—Mitomycin—stomach cancer	0.00357	0.0111	CcSEcCtD
Cyclopentolate—Lacrimation increased—Capecitabine—stomach cancer	0.00355	0.011	CcSEcCtD
Cyclopentolate—Paralysis—Methotrexate—stomach cancer	0.0035	0.0109	CcSEcCtD
Cyclopentolate—BCHE—liver—stomach cancer	0.00343	0.0191	CbGeAlD
Cyclopentolate—Coordination abnormal—Capecitabine—stomach cancer	0.00333	0.0103	CcSEcCtD
Cyclopentolate—Paralysis—Epirubicin—stomach cancer	0.00328	0.0102	CcSEcCtD
Cyclopentolate—Rash—Floxuridine—stomach cancer	0.00323	0.00999	CcSEcCtD
Cyclopentolate—Dermatitis—Floxuridine—stomach cancer	0.00322	0.00998	CcSEcCtD
Cyclopentolate—Ataxia—Fluorouracil—stomach cancer	0.00319	0.0099	CcSEcCtD
Cyclopentolate—Abdominal distension—Irinotecan—stomach cancer	0.00309	0.00956	CcSEcCtD
Cyclopentolate—Paralysis—Doxorubicin—stomach cancer	0.00303	0.0094	CcSEcCtD
Cyclopentolate—Gastroenteritis—Capecitabine—stomach cancer	0.00268	0.0083	CcSEcCtD
Cyclopentolate—BCHE—lymph node—stomach cancer	0.00263	0.0146	CbGeAlD
Cyclopentolate—Vasodilation procedure—Epirubicin—stomach cancer	0.00259	0.00803	CcSEcCtD
Cyclopentolate—Vasodilation—Epirubicin—stomach cancer	0.00259	0.00803	CcSEcCtD
Cyclopentolate—Conjunctivitis—Fluorouracil—stomach cancer	0.00254	0.00788	CcSEcCtD
Cyclopentolate—Rash—Mitomycin—stomach cancer	0.00253	0.00784	CcSEcCtD
Cyclopentolate—Dermatitis—Mitomycin—stomach cancer	0.00253	0.00783	CcSEcCtD
Cyclopentolate—Lacrimation increased—Epirubicin—stomach cancer	0.00247	0.00766	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Doxorubicin—stomach cancer	0.0024	0.00743	CcSEcCtD
Cyclopentolate—Vasodilation—Doxorubicin—stomach cancer	0.0024	0.00743	CcSEcCtD
Cyclopentolate—Coordination abnormal—Epirubicin—stomach cancer	0.00232	0.00719	CcSEcCtD
Cyclopentolate—Ataxia—Docetaxel—stomach cancer	0.00231	0.00714	CcSEcCtD
Cyclopentolate—Lacrimation increased—Doxorubicin—stomach cancer	0.00229	0.00709	CcSEcCtD
Cyclopentolate—Flushing—Irinotecan—stomach cancer	0.00228	0.00706	CcSEcCtD
Cyclopentolate—Urinary retention—Capecitabine—stomach cancer	0.00226	0.00699	CcSEcCtD
Cyclopentolate—Ataxia—Capecitabine—stomach cancer	0.00223	0.00692	CcSEcCtD
Cyclopentolate—Coma—Methotrexate—stomach cancer	0.00222	0.00689	CcSEcCtD
Cyclopentolate—Coordination abnormal—Doxorubicin—stomach cancer	0.00215	0.00665	CcSEcCtD
Cyclopentolate—Coma—Epirubicin—stomach cancer	0.00208	0.00645	CcSEcCtD
Cyclopentolate—Abdominal distension—Capecitabine—stomach cancer	0.00207	0.0064	CcSEcCtD
Cyclopentolate—Vision blurred—Fluorouracil—stomach cancer	0.00193	0.00597	CcSEcCtD
Cyclopentolate—Coma—Doxorubicin—stomach cancer	0.00193	0.00597	CcSEcCtD
Cyclopentolate—Vertigo—Irinotecan—stomach cancer	0.00192	0.00595	CcSEcCtD
Cyclopentolate—Conjunctivitis—Docetaxel—stomach cancer	0.00184	0.00569	CcSEcCtD
Cyclopentolate—Conjunctivitis—Capecitabine—stomach cancer	0.00178	0.00551	CcSEcCtD
Cyclopentolate—Convulsion—Fluorouracil—stomach cancer	0.00177	0.00549	CcSEcCtD
Cyclopentolate—Ataxia—Methotrexate—stomach cancer	0.00166	0.00515	CcSEcCtD
Cyclopentolate—Tachycardia—Fluorouracil—stomach cancer	0.00163	0.00505	CcSEcCtD
Cyclopentolate—Flushing—Docetaxel—stomach cancer	0.00157	0.00488	CcSEcCtD
Cyclopentolate—Ataxia—Epirubicin—stomach cancer	0.00156	0.00482	CcSEcCtD
Cyclopentolate—Somnolence—Irinotecan—stomach cancer	0.00155	0.0048	CcSEcCtD
Cyclopentolate—Flushing—Capecitabine—stomach cancer	0.00152	0.00472	CcSEcCtD
Cyclopentolate—Somnolence—Fluorouracil—stomach cancer	0.00148	0.0046	CcSEcCtD
Cyclopentolate—Abdominal distension—Epirubicin—stomach cancer	0.00144	0.00446	CcSEcCtD
Cyclopentolate—Ataxia—Doxorubicin—stomach cancer	0.00144	0.00446	CcSEcCtD
Cyclopentolate—Drowsiness—Methotrexate—stomach cancer	0.00136	0.00422	CcSEcCtD
Cyclopentolate—Vision blurred—Capecitabine—stomach cancer	0.00135	0.00417	CcSEcCtD
Cyclopentolate—Tremor—Capecitabine—stomach cancer	0.00134	0.00415	CcSEcCtD
Cyclopentolate—Abdominal distension—Doxorubicin—stomach cancer	0.00133	0.00413	CcSEcCtD
Cyclopentolate—Conjunctivitis—Methotrexate—stomach cancer	0.00132	0.0041	CcSEcCtD
Cyclopentolate—Vertigo—Capecitabine—stomach cancer	0.00128	0.00398	CcSEcCtD
Cyclopentolate—Convulsion—Docetaxel—stomach cancer	0.00128	0.00396	CcSEcCtD
Cyclopentolate—Drowsiness—Epirubicin—stomach cancer	0.00127	0.00395	CcSEcCtD
Cyclopentolate—Conjunctivitis—Epirubicin—stomach cancer	0.00124	0.00384	CcSEcCtD
Cyclopentolate—Dry mouth—Docetaxel—stomach cancer	0.00123	0.00381	CcSEcCtD
Cyclopentolate—Dry mouth—Capecitabine—stomach cancer	0.00119	0.00369	CcSEcCtD
Cyclopentolate—Pruritus—Fluorouracil—stomach cancer	0.00118	0.00366	CcSEcCtD
Cyclopentolate—Drowsiness—Doxorubicin—stomach cancer	0.00118	0.00365	CcSEcCtD
Cyclopentolate—Tachycardia—Docetaxel—stomach cancer	0.00118	0.00364	CcSEcCtD
Cyclopentolate—Conjunctivitis—Doxorubicin—stomach cancer	0.00115	0.00355	CcSEcCtD
Cyclopentolate—Tachycardia—Capecitabine—stomach cancer	0.00114	0.00353	CcSEcCtD
Cyclopentolate—Rash—Irinotecan—stomach cancer	0.0011	0.00341	CcSEcCtD
Cyclopentolate—Dermatitis—Irinotecan—stomach cancer	0.0011	0.0034	CcSEcCtD
Cyclopentolate—Somnolence—Docetaxel—stomach cancer	0.00107	0.00332	CcSEcCtD
Cyclopentolate—Flushing—Epirubicin—stomach cancer	0.00106	0.00329	CcSEcCtD
Cyclopentolate—Rash—Fluorouracil—stomach cancer	0.00105	0.00326	CcSEcCtD
Cyclopentolate—Dermatitis—Fluorouracil—stomach cancer	0.00105	0.00326	CcSEcCtD
Cyclopentolate—Vision blurred—Methotrexate—stomach cancer	0.001	0.00311	CcSEcCtD
Cyclopentolate—Flushing—Doxorubicin—stomach cancer	0.000982	0.00304	CcSEcCtD
Cyclopentolate—Vertigo—Methotrexate—stomach cancer	0.000956	0.00296	CcSEcCtD
Cyclopentolate—Vision blurred—Epirubicin—stomach cancer	0.000939	0.00291	CcSEcCtD
Cyclopentolate—Convulsion—Methotrexate—stomach cancer	0.000922	0.00286	CcSEcCtD
Cyclopentolate—Agitation—Epirubicin—stomach cancer	0.000915	0.00284	CcSEcCtD
Cyclopentolate—Vertigo—Epirubicin—stomach cancer	0.000895	0.00277	CcSEcCtD
Cyclopentolate—Vision blurred—Doxorubicin—stomach cancer	0.000868	0.00269	CcSEcCtD
Cyclopentolate—Convulsion—Epirubicin—stomach cancer	0.000863	0.00267	CcSEcCtD
Cyclopentolate—Pruritus—Docetaxel—stomach cancer	0.000853	0.00264	CcSEcCtD
Cyclopentolate—Agitation—Doxorubicin—stomach cancer	0.000847	0.00262	CcSEcCtD
Cyclopentolate—Dry mouth—Epirubicin—stomach cancer	0.000829	0.00257	CcSEcCtD
Cyclopentolate—Vertigo—Doxorubicin—stomach cancer	0.000828	0.00257	CcSEcCtD
Cyclopentolate—Pruritus—Capecitabine—stomach cancer	0.000825	0.00256	CcSEcCtD
Cyclopentolate—Convulsion—Doxorubicin—stomach cancer	0.000798	0.00247	CcSEcCtD
Cyclopentolate—Tachycardia—Epirubicin—stomach cancer	0.000793	0.00246	CcSEcCtD
Cyclopentolate—Somnolence—Methotrexate—stomach cancer	0.000772	0.00239	CcSEcCtD
Cyclopentolate—Dry mouth—Doxorubicin—stomach cancer	0.000767	0.00238	CcSEcCtD
Cyclopentolate—Rash—Docetaxel—stomach cancer	0.00076	0.00235	CcSEcCtD
Cyclopentolate—Dermatitis—Docetaxel—stomach cancer	0.000759	0.00235	CcSEcCtD
Cyclopentolate—Rash—Capecitabine—stomach cancer	0.000736	0.00228	CcSEcCtD
Cyclopentolate—Dermatitis—Capecitabine—stomach cancer	0.000735	0.00228	CcSEcCtD
Cyclopentolate—Tachycardia—Doxorubicin—stomach cancer	0.000734	0.00227	CcSEcCtD
Cyclopentolate—Somnolence—Epirubicin—stomach cancer	0.000723	0.00224	CcSEcCtD
Cyclopentolate—Somnolence—Doxorubicin—stomach cancer	0.000669	0.00207	CcSEcCtD
Cyclopentolate—Pruritus—Methotrexate—stomach cancer	0.000614	0.0019	CcSEcCtD
Cyclopentolate—Pruritus—Epirubicin—stomach cancer	0.000575	0.00178	CcSEcCtD
Cyclopentolate—Rash—Methotrexate—stomach cancer	0.000548	0.0017	CcSEcCtD
Cyclopentolate—Dermatitis—Methotrexate—stomach cancer	0.000547	0.0017	CcSEcCtD
Cyclopentolate—Pruritus—Doxorubicin—stomach cancer	0.000532	0.00165	CcSEcCtD
Cyclopentolate—Rash—Epirubicin—stomach cancer	0.000512	0.00159	CcSEcCtD
Cyclopentolate—Dermatitis—Epirubicin—stomach cancer	0.000512	0.00159	CcSEcCtD
Cyclopentolate—Rash—Doxorubicin—stomach cancer	0.000474	0.00147	CcSEcCtD
Cyclopentolate—Dermatitis—Doxorubicin—stomach cancer	0.000474	0.00147	CcSEcCtD
Cyclopentolate—CHRM3—Metabolism—PDHA1—stomach cancer	0.000107	0.000958	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ECHS1—stomach cancer	0.000107	0.000958	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	0.000107	0.000958	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	0.000107	0.000955	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ALOX5—stomach cancer	0.000106	0.000944	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—HTR1A—stomach cancer	0.000105	0.00094	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—HTR1A—stomach cancer	0.000105	0.000937	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—DPYD—stomach cancer	0.000104	0.000929	CbGpPWpGaD
Cyclopentolate—CHRM1—Regulation of Actin Cytoskeleton—PIK3CA—stomach cancer	0.000103	0.000918	CbGpPWpGaD
Cyclopentolate—CHRM3—Regulation of Actin Cytoskeleton—PIK3CA—stomach cancer	0.000103	0.000915	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—ANXA1—stomach cancer	0.000102	0.000908	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—ANXA1—stomach cancer	0.000101	0.000905	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—WIF1—stomach cancer	0.000101	0.000902	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HRH4—stomach cancer	0.000101	0.000902	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—TYMP—stomach cancer	0.000101	0.000901	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—FADS1—stomach cancer	0.000101	0.000901	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HRH4—stomach cancer	0.000101	0.000899	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—WIF1—stomach cancer	0.000101	0.000899	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AGTR2—stomach cancer	9.94e-05	0.000886	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AGTR2—stomach cancer	9.91e-05	0.000884	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—ADRB1—stomach cancer	9.85e-05	0.000879	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—F2R—stomach cancer	9.83e-05	0.000877	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—ADRB1—stomach cancer	9.82e-05	0.000876	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—F2R—stomach cancer	9.8e-05	0.000874	CbGpPWpGaD
Cyclopentolate—BCHE—Transmission across Chemical Synapses—HRAS—stomach cancer	9.76e-05	0.00087	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—HTR1A—stomach cancer	9.57e-05	0.000853	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—HTR1A—stomach cancer	9.54e-05	0.000851	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—SREBF2—stomach cancer	9.46e-05	0.000843	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	9.44e-05	0.000842	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—RORA—stomach cancer	9.34e-05	0.000833	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PRKAB1—stomach cancer	9.33e-05	0.000832	CbGpPWpGaD
Cyclopentolate—BCHE—Neuronal System—MAPK1—stomach cancer	9.31e-05	0.00083	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PRKAB1—stomach cancer	9.3e-05	0.000829	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	9.3e-05	0.000829	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	9.27e-05	0.000827	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—ANXA1—stomach cancer	9.24e-05	0.000824	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—ANXA1—stomach cancer	9.21e-05	0.000822	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GSTT1—stomach cancer	9.21e-05	0.000821	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CYP2A6—stomach cancer	9.1e-05	0.000812	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—KISS1—stomach cancer	9.01e-05	0.000804	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RNF43—stomach cancer	9.01e-05	0.000804	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—KISS1—stomach cancer	8.98e-05	0.000801	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RNF43—stomach cancer	8.98e-05	0.000801	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	8.96e-05	0.000799	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—ADRB1—stomach cancer	8.95e-05	0.000798	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	8.93e-05	0.000797	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—ADRB1—stomach cancer	8.92e-05	0.000796	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—AKR1C3—stomach cancer	8.85e-05	0.00079	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	8.85e-05	0.000789	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	8.85e-05	0.000789	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	8.82e-05	0.000787	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	8.82e-05	0.000786	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ALDOB—stomach cancer	8.76e-05	0.000781	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ENO1—stomach cancer	8.63e-05	0.00077	CbGpPWpGaD
Cyclopentolate—CHRM1—G alpha (q) signalling events—PIK3CA—stomach cancer	8.58e-05	0.000766	CbGpPWpGaD
Cyclopentolate—CHRM3—G alpha (q) signalling events—PIK3CA—stomach cancer	8.56e-05	0.000763	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—ALB—stomach cancer	8.49e-05	0.000757	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	8.36e-05	0.000745	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	8.33e-05	0.000743	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ALOX5—stomach cancer	8.14e-05	0.000726	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FST—stomach cancer	8.03e-05	0.000716	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—DPYD—stomach cancer	8.01e-05	0.000714	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FST—stomach cancer	8e-05	0.000714	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—ADRB2—stomach cancer	7.98e-05	0.000712	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—ADRB2—stomach cancer	7.96e-05	0.00071	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—HBEGF—stomach cancer	7.86e-05	0.000701	CbGpPWpGaD
Cyclopentolate—CHRM1—Circadian rythm related genes—TP53—stomach cancer	7.84e-05	0.000699	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—HBEGF—stomach cancer	7.83e-05	0.000699	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GAST—stomach cancer	7.75e-05	0.000691	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RGS2—stomach cancer	7.75e-05	0.000691	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RGS2—stomach cancer	7.72e-05	0.000689	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GAST—stomach cancer	7.72e-05	0.000689	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	7.68e-05	0.000685	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CD44—stomach cancer	7.65e-05	0.000683	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	7.65e-05	0.000683	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—MMP2—stomach cancer	7.49e-05	0.000668	CbGpPWpGaD
Cyclopentolate—BCHE—Neuronal System—HRAS—stomach cancer	7.47e-05	0.000667	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	7.43e-05	0.000662	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FGG—stomach cancer	7.34e-05	0.000655	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FGG—stomach cancer	7.32e-05	0.000653	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—ADRB2—stomach cancer	7.25e-05	0.000647	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—ADRB2—stomach cancer	7.23e-05	0.000645	CbGpPWpGaD
Cyclopentolate—CHRM1—Circadian rythm related genes—IL6—stomach cancer	7.17e-05	0.00064	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PPP2R1A—stomach cancer	7.11e-05	0.000634	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	7.1e-05	0.000633	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PPP2R1A—stomach cancer	7.08e-05	0.000632	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GSTT1—stomach cancer	7.08e-05	0.000632	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	7.08e-05	0.000631	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PRKAA1—stomach cancer	7.07e-05	0.000631	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PRKAA1—stomach cancer	7.05e-05	0.000629	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CYP2A6—stomach cancer	7e-05	0.000624	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RBP4—stomach cancer	6.83e-05	0.000609	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—CXCL8—stomach cancer	6.82e-05	0.000609	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—AKR1C3—stomach cancer	6.81e-05	0.000607	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RBP4—stomach cancer	6.81e-05	0.000607	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—CXCL8—stomach cancer	6.8e-05	0.000607	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	6.8e-05	0.000606	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	6.78e-05	0.000604	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ENO1—stomach cancer	6.64e-05	0.000592	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PPP2R1A—stomach cancer	6.51e-05	0.00058	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GSTP1—stomach cancer	6.38e-05	0.000569	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—HMOX1—stomach cancer	6.3e-05	0.000561	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—CXCL8—stomach cancer	6.22e-05	0.000555	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—TYMS—stomach cancer	5.93e-05	0.000529	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CD44—stomach cancer	5.88e-05	0.000525	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AGTR2—stomach cancer	5.87e-05	0.000524	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HSPB1—stomach cancer	5.87e-05	0.000524	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GSTM1—stomach cancer	5.87e-05	0.000523	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AGTR2—stomach cancer	5.85e-05	0.000522	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HSPB1—stomach cancer	5.85e-05	0.000522	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—F2R—stomach cancer	5.81e-05	0.000518	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—BMP2—stomach cancer	5.81e-05	0.000518	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—BMP2—stomach cancer	5.79e-05	0.000516	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—F2R—stomach cancer	5.79e-05	0.000516	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AKR1C3—stomach cancer	5.71e-05	0.000509	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AKR1C3—stomach cancer	5.69e-05	0.000508	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HTR1A—stomach cancer	5.65e-05	0.000504	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HTR1A—stomach cancer	5.63e-05	0.000502	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ERCC2—stomach cancer	5.51e-05	0.000492	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PRKCB—stomach cancer	5.47e-05	0.000488	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ANXA1—stomach cancer	5.46e-05	0.000487	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PRKCB—stomach cancer	5.46e-05	0.000487	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ANXA1—stomach cancer	5.44e-05	0.000485	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ADRB1—stomach cancer	5.29e-05	0.000472	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ADRB1—stomach cancer	5.27e-05	0.00047	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—MTHFR—stomach cancer	5.18e-05	0.000462	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RPS6—stomach cancer	5.05e-05	0.00045	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RPS6—stomach cancer	5.03e-05	0.000449	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PPP2R1A—stomach cancer	5e-05	0.000446	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PRKCB—stomach cancer	4.97e-05	0.000443	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PRKCB—stomach cancer	4.95e-05	0.000442	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—IL6ST—stomach cancer	4.95e-05	0.000441	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—IL6ST—stomach cancer	4.93e-05	0.00044	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GSTP1—stomach cancer	4.91e-05	0.000438	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—HMOX1—stomach cancer	4.84e-05	0.000432	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CAV1—stomach cancer	4.78e-05	0.000426	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—APOA1—stomach cancer	4.77e-05	0.000426	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HBEGF—stomach cancer	4.64e-05	0.000414	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HBEGF—stomach cancer	4.63e-05	0.000413	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.57e-05	0.000407	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—TYMS—stomach cancer	4.56e-05	0.000407	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GSTM1—stomach cancer	4.51e-05	0.000402	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—IL6R—stomach cancer	4.42e-05	0.000394	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—IL6R—stomach cancer	4.4e-05	0.000393	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—RHOA—stomach cancer	4.39e-05	0.000392	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—RHOA—stomach cancer	4.38e-05	0.000391	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ADRB2—stomach cancer	4.28e-05	0.000382	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ADRB2—stomach cancer	4.27e-05	0.000381	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ERCC2—stomach cancer	4.24e-05	0.000378	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PPARG—stomach cancer	4.2e-05	0.000375	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PPP2R1A—stomach cancer	4.2e-05	0.000374	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PPP2R1A—stomach cancer	4.18e-05	0.000373	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—RHOA—stomach cancer	3.99e-05	0.000356	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—MTHFR—stomach cancer	3.99e-05	0.000356	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—RHOA—stomach cancer	3.98e-05	0.000355	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SMAD4—stomach cancer	3.9e-05	0.000348	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SMAD4—stomach cancer	3.88e-05	0.000347	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—CXCL8—stomach cancer	3.86e-05	0.000344	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—CXCL8—stomach cancer	3.84e-05	0.000343	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ALB—stomach cancer	3.78e-05	0.000337	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FYN—stomach cancer	3.7e-05	0.00033	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FYN—stomach cancer	3.69e-05	0.000329	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CAV1—stomach cancer	3.68e-05	0.000328	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—APOA1—stomach cancer	3.67e-05	0.000327	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—NOS3—stomach cancer	3.62e-05	0.000322	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CXCL8—stomach cancer	3.5e-05	0.000312	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CXCL8—stomach cancer	3.49e-05	0.000311	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FGFR2—stomach cancer	3.47e-05	0.00031	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FGFR2—stomach cancer	3.46e-05	0.000309	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PTGS2—stomach cancer	3.31e-05	0.000295	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PPARG—stomach cancer	3.23e-05	0.000288	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IRS2—stomach cancer	3.18e-05	0.000284	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IRS2—stomach cancer	3.17e-05	0.000283	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CAV1—stomach cancer	3.08e-05	0.000275	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APOA1—stomach cancer	3.08e-05	0.000274	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CAV1—stomach cancer	3.07e-05	0.000274	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APOA1—stomach cancer	3.07e-05	0.000274	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PRKCB—stomach cancer	2.94e-05	0.000262	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PRKCB—stomach cancer	2.93e-05	0.000261	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IL6ST—stomach cancer	2.92e-05	0.000261	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IL6ST—stomach cancer	2.91e-05	0.00026	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ALB—stomach cancer	2.91e-05	0.000259	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APC—stomach cancer	2.81e-05	0.000251	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APC—stomach cancer	2.8e-05	0.00025	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—NOS3—stomach cancer	2.78e-05	0.000248	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—MAPK3—stomach cancer	2.69e-05	0.00024	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—MAPK3—stomach cancer	2.68e-05	0.000239	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IL6R—stomach cancer	2.61e-05	0.000233	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IL6R—stomach cancer	2.6e-05	0.000232	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—MAPK1—stomach cancer	2.56e-05	0.000228	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—EGFR—stomach cancer	2.56e-05	0.000228	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—MAPK1—stomach cancer	2.55e-05	0.000228	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—EGFR—stomach cancer	2.55e-05	0.000228	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PTGS2—stomach cancer	2.54e-05	0.000227	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PIK3CA—stomach cancer	2.45e-05	0.000218	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SERPINE1—stomach cancer	2.44e-05	0.000218	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PIK3CA—stomach cancer	2.44e-05	0.000217	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SERPINE1—stomach cancer	2.43e-05	0.000217	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—KRAS—stomach cancer	2.42e-05	0.000216	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—KRAS—stomach cancer	2.41e-05	0.000215	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RHOA—stomach cancer	2.36e-05	0.00021	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RHOA—stomach cancer	2.35e-05	0.00021	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NOS3—stomach cancer	2.33e-05	0.000208	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NOS3—stomach cancer	2.32e-05	0.000207	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PIK3CA—stomach cancer	2.22e-05	0.000198	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PIK3CA—stomach cancer	2.21e-05	0.000198	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ERBB2—stomach cancer	2.18e-05	0.000195	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ERBB2—stomach cancer	2.17e-05	0.000194	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CXCL8—stomach cancer	2.07e-05	0.000185	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CXCL8—stomach cancer	2.06e-05	0.000184	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—HRAS—stomach cancer	2.06e-05	0.000183	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—HRAS—stomach cancer	2.05e-05	0.000183	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PIK3CA—stomach cancer	2.03e-05	0.000181	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	2.02e-05	0.00018	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CDKN1B—stomach cancer	2.01e-05	0.00018	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—IL6—stomach cancer	1.97e-05	0.000175	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—IL6—stomach cancer	1.96e-05	0.000175	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCND1—stomach cancer	1.93e-05	0.000172	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—JUN—stomach cancer	1.92e-05	0.000172	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCND1—stomach cancer	1.92e-05	0.000171	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—JUN—stomach cancer	1.92e-05	0.000171	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MMP9—stomach cancer	1.87e-05	0.000167	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MMP9—stomach cancer	1.87e-05	0.000166	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	1.86e-05	0.000166	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CDKN1A—stomach cancer	1.86e-05	0.000166	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MAPK8—stomach cancer	1.82e-05	0.000162	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MAPK8—stomach cancer	1.81e-05	0.000162	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—VEGFA—stomach cancer	1.68e-05	0.00015	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—VEGFA—stomach cancer	1.67e-05	0.000149	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—STAT3—stomach cancer	1.66e-05	0.000148	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—STAT3—stomach cancer	1.66e-05	0.000148	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MAPK3—stomach cancer	1.59e-05	0.000142	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MAPK3—stomach cancer	1.58e-05	0.000141	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PIK3CA—stomach cancer	1.56e-05	0.00014	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MYC—stomach cancer	1.55e-05	0.000138	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MYC—stomach cancer	1.54e-05	0.000137	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MAPK1—stomach cancer	1.51e-05	0.000135	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EGFR—stomach cancer	1.51e-05	0.000135	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MAPK1—stomach cancer	1.51e-05	0.000134	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EGFR—stomach cancer	1.51e-05	0.000134	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—KRAS—stomach cancer	1.43e-05	0.000127	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—KRAS—stomach cancer	1.42e-05	0.000127	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	1.31e-05	0.000117	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PIK3CA—stomach cancer	1.31e-05	0.000117	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TP53—stomach cancer	1.27e-05	0.000113	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TP53—stomach cancer	1.27e-05	0.000113	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HRAS—stomach cancer	1.21e-05	0.000108	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HRAS—stomach cancer	1.21e-05	0.000108	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IL6—stomach cancer	1.16e-05	0.000104	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IL6—stomach cancer	1.16e-05	0.000103	CbGpPWpGaD
